Year-end Sale % OFF 
Abstract
In PLoS Biology, volume 2, issue 11: DOI: 10.1371/journal.pbio.0020363 We incorrectly named the products of two genes, gamma actin and betaAPP, as FMRP ligands because of a misreading of Table 1 from [1]. BetaAPP is incorrectly referred to as an FMRP ligand in Tables 2 and S9, gamma actin in Table S9 only. This does not change the use of FMRP binding as a way to support the target predictions, as the statistics remain virtually the same; the enrichment of FMRP targets within the predicted microRNA target set changes from 5.31 to 5.26 as a result of our misclassification. In addition, it does not change the fact that betaAPP is a predicted microRNA target. Our Web site at http://www.microrna.org/ contains the updated information with changes flagged. We thank Dr. Denman for pointing out this error to us.
Highlights
In PLoS Biology, volume 2, issue 11: We incorrectly named the products of two genes, gamma actin and betaAPP, as FMRP ligands because of a misreading of Table 1 from [1]
BetaAPP is incorrectly referred to as an FMRP ligand in Tables 2 and S9, gamma actin in Table S9 only. This does not change the use of FMRP binding as a way to support the target predictions, as the statistics remain virtually the same; the enrichment of FMRP targets within the predicted microRNA target set changes from 5.31 to 5.26 as a result of our misclassification
It does not change the fact that betaAPP is a predicted microRNA target
Summary
In PLoS Biology, volume 2, issue 11: We incorrectly named the products of two genes, gamma actin and betaAPP, as FMRP ligands because of a misreading of Table 1 from [1].
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
